Literature DB >> 26157556

Evaluation of Eye Irritation Potential of Solid Substance with New 3D Reconstructed Human Cornea Model, MCTT HCE(TM).

Won-Hee Jang1, Kyoung-Mi Jung1, Hye-Ri Yang2, Miri Lee2, Haeng-Sun Jung3, Su-Hyon Lee3, Miyoung Park1, Kyung-Min Lim2.   

Abstract

The eye irritation potential of drug candidates or pharmaceutical ingredients should be evaluated if there is a possibility of ocular exposure. Traditionally, the ocular irritation has been evaluated by the rabbit Draize test. However, rabbit eyes are more sensitive to irritants than human eyes, therefore substantial level of false positives are unavoidable. To resolve this species difference, several three-dimensional human corneal epithelial (HCE) models have been developed as alternative eye irritation test methods. Recently, we introduced a new HCE model, MCTT HCE(TM) which is reconstructed with non-transformed human corneal cells from limbal tissues. Here, we examined if MCTT HCE(TM) can be employed to evaluate eye irritation potential of solid substances. Through optimization of washing method and exposure time, treatment time was established as 10 min and washing procedure was set up as 4 times of washing with 10 mL of PBS and shaking in 30 mL of PBS in a beaker. With the established eye irritation test protocol, 11 solid substances (5 non-irritants, 6 irritants) were evaluated which demonstrated an excellent predictive capacity (100% accuracy, 100% specificity and 100% sensitivity). We also compared the performance of our test method with rabbit Draize test results and in vitro cytotoxicity test with 2D human corneal epithelial cell lines.

Entities:  

Keywords:  Eye irritation; MCTT HCETM model; Protocol refinement; Reconstructed cornea model

Year:  2015        PMID: 26157556      PMCID: PMC4489834          DOI: 10.4062/biomolther.2015.004

Source DB:  PubMed          Journal:  Biomol Ther (Seoul)        ISSN: 1976-9148            Impact factor:   4.634


INTRODUCTION

The eye irritation potential of new drug candidates or pharmaceutical ingredients should be evaluated during the pre-clinical stage of development process if there is a possibility of ocular exposure. The representative example is benzalkonium chloride which is the most widely used preservative in the eye drop (Okahara and Kawazu, 2013). In order to evaluate eye irritation potential of ophthalmic agents and other substances with the possibility of direct ocular exposure, the rabbit Draize test (OECD, 2002) has been commonly employed. However, rabbit eyes are more sensitive to eye irritation than human eyes therefore, overestimation of eye irritation potential is unavoidable (Prinsen, 2006; Adriaens ). In addition, consideration of animal welfare have been increased recently (Jang ), demanding a new alternative test method to replace rabbit eye Draize test. Many alternative approaches to rabbit eye Draize test have been developed such as bovine corneal opacity permeability (BCOP) test (Cater and Harbell, 2006) and hen’s egg chorioallantonic membrane (HET-CAM) test (Spielmann ). Validation study for BCOP test (OECD, 2013a), isolated chicken eye test (OECD, 2013b) and fluorescein leakage test (OECD, 2012) had been successfully completed by the European Center for the Validation of Alternative Methods (ECVAM) and the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and these were registered in the ‘Organization for Economic Cooperation and Development (OECD) Guidelines for the Testing of Chemicals’. However, these test methods still have many shortcomings such as use of non-human tissue, applicability limited to ocular corrosives and severe irritants, and unsatisfactory predictive capacity for human ocular irritation, reflecting a considerable demand for novel and more human-like alternative tests. Since eye irritants affect corneal epithelium directly, the disruption of structural integrity, and decreased viability of the cornea are important indices of eye irritation. Eye irritants can cause lysis of membranes or denaturation of proteins or interaction with macromolecules in the cornea (Kaluzhny ). In this background, in vitro eye irritation tests were developed using human corneal epithelium cell line (Cho ) or reconstructed human corneal epithelium (HCE). Especially, reconstructed HCE models well recapitulate the stratified and differentiated human cornea epithelium and can be applied to solid substances that are prevalent in ophthalmologic drugs (Liang ) or medical devices (Postnikoff ). Three HCE models have been reported up to now; EpiOcularTM (MatTek, Ashland, MA, USA) model prepared with normal human epidermal keratinocyte (Stern ; Kaluzhny ), SkinEthicTM Reconstituted Human Corneal Epithelium (SkinEthic, Lyon, France) model with immortalized human corneal epithelial cell line (Van Goethem ) and LabCyte CORNEA-MODEL (Japan Tissue Engineering Co., Ltd, Gamagori, Aichi, Japan) with normal human corneal epithelial cells (Katoh ). Recently, we have reported a new HCE model, MCTT HCETM (Modern Cell & Tissue Technologies, Seoul, Korea), which is reconstructed from primary-cultured human corneal epithelial cells (Jung ). MCTT HCETM model has human cornea-like structure with 3 distinct differentiated layers, i.e., basal cell layer, wing cell layer and superficial squamous cells layer. And the biomarkers for cornea such as CD44v6 and MUC1 are well-expressed. Eye irritation test with MCTT HCETM model showed the accuracy of 88%, sensitivity of 100% and specificity of 77% for 25 liquid reference compounds but its utility in the evaluation of solid substances has not been demonstrated. In the present study, we established eye irritation test method with MCTT HCETM model for solid substances and evaluated the predictive capacity of the developed method with 11 known references (Table 1).
Table 1.

List of solid test substances

Test substanceAbbreviationCAS No.MMASGHSRef.
PhenothiazineP92-84-20NI(1) (2)
Aluminum hydroxideAH21645-51-212.7(1) (2)
Potassium tetrafluoroboratePT14075-53-70(1)
trans-cinnamic acidt-CA140-10-3-(2)
Glyceryl stearate (Glycerol triisostearate)GS123-94-42.0(2)
Ammonium nitrateAN6484-52-218.3Cat 2(1)
Citric acidCA77-92-917.4(2)
ChlorhexidineCH55-56-182.3Cat I(1)
QuinacrineQ69-05-682(1) (2)
Promethazine hydrochloridePH58-33-371.7/84.0(1)
Zinc gluconateZG4468-02-4-(2)

Kaluzhny ,

Alépée .

MATERIALS AND METHODS

Tissues

MCTTTM HCE, Reconstituted human corneal epithelium tissue, was supplied by MCTT Co. (Seoul, Korea). Human primary limbal epithelial cells obtained from corneal transplantation were cultured on an insert (0.6 cm2 polycarbonate Millicell® cell culture insert, Millipore, Darmstadt, Germany) for 14 days.

Media and reagents

Maintenance medium was supplied by MCTT Co. Sodium lauryl sulfate for positive control, quinacrine, chlorhexidine, promethazine hydrochloride, potassium tetrafluoroborate, phenothiazine, aluminum hydroxide, t-cinnamic acid, glyceryl stearate, ammonium nitrate, citric acid, zinc gluconate, pyridine and PBS for washing was obtained from Sigma (St. Louis, MO, USA). WST-1 (4-[3-(4-lodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) for measuring cell viability was supplied by Roche (Basel, Switzerland).

Experimental protocol refinement

Overall experimental protocol: After MCTTTM HCE was incubated 22 ± 2 hr at 37°C in 5% CO2 incubator, 40 mg of solid test article was topically applied on the HCE pre-wetted with 40 μL of PBS (Fig. 1C). Tissues were rinsed with PBS after treatment and post-incubated for 16 ± 1 hr at 37°C in 5% CO2 incubator. And then HCE was incubated with WST-1 for 3 hr to measure cell viability. Absorbance of formazan was measured at 450 nm using the UV spectrophotometer. The mean of 2 wells for each test substance was calculated.
Fig. 1.

Optimization of treatment time of test substance and washing method. (A) Effects of application time (B) and washing method on tissue viability (n=2–3). (C) Photographs of treatment of solid substance and washing procedure. Values are mean and error bars indicates absolute value ([Tissue1−Tissue2]/2) (n=2∼3).

Determination of the treatment time: Test articles were treated for 10 or 30 min at 37°C in 5% CO2 incubator. Other procedure was performed as above. Determination of washing method: Test articles were treated for 10 min and rinsed with several conditions using PBS. For rinsing the tissues, ‘Wash 1’ method was followed by retention with PBS for 1 min and washing 2 times with 10 mL of PBS and shaking in 4 mL of PBS in the 12 well plate. ‘Wash 2’ method was followed by washing 4 times with 10 mL of PBS and shaking in 30 mL of PBS in the beaker. ‘Wash 3’ method was followed by rinsing 4 times with 10 mL of PBS and shaking in 30 mL of PBS in the beaker 2 times, after that soaking in 4 mL of media in the 12 well plate for 10 min at 37°C in 5% CO2 incubator. Other procedure was performed as above.

Prediction model

OD of negative control was converted to 100% of cell viability and OD of test material was changed into a percentage. If the cell viability was above than 50%, the test substance was judged to be a non-irritant, otherwise, it was determined an eye-irritant.

Cytotoxicity assessment of human corneal epithelial cells (HCE-T)

Cytotoxicity of some irritants were done according to Cho . Human corneal epithelial cells (HCE-T) which were transformed with SV-40 adenovirus vector (Araki-Sasaki ) established by Dr. Kaoru Araki-Sasaki (Osaka University, Osaka, Japan), were kindly provided by Dr. Choun-Ki Joo (Catholic University of Korea, Seoul, Korea). The cells were cultured in DMEM/F-12 medium (Lonza, NJ, USA) containing 5% FBS (Gibco, California, USA), 5 μg/mL recombinant human insulin (Sigma-Aldrich), 10 ng/mL human EGF (Sigma-Aldrich), 100 ng/ml cholera toxin (Biomol, Allemagne, Germany), and 0.5% DMSO (Sigma-Aldrich) (Seomun and Joo, 2008). HCE-T cells were seeded in 96-well plates(2×104 cells/well), and grown for 48 hr in a humidified atmosphere of 5% CO2 at 37°C until the cells attained full confluence. The cells in the 96-well plates were exposed to 200 μL of test material solution for 1 h. After the exposure, the cells were washed 3 times with 200 μL of phosphate-buffered saline (PBS) (Lonza), and then, 100 μL of methylthiazolyldiphenyl tetrazolium bromide (MTT) (Sigma-Aldrich) solution (0.5 mg/mL in cell culture medium) was added. After 3-h incubation, the cells were washed 3 times with PBS. MTT formazan was extracted with 100 μL of 0.04 N HCl-isopropanol (Sigma-Aldrich) for 30 min, and the absorbance of the extract was measured at 570 nm with a spectrophotometer (Molecular Devices, Sunnyvale, USA).

Statistics

Values are mean and error bars indicates absolute difference between duplicate tissue ([Tissue1−Tissue2]/2) (n=2)

RESULTS

Optimization of treatment time of test substance

Firstly, experiments were performed according to the method developed for liquid test articles, i.e., exposure periods of 10 min and 4 times of washing and post-incubation time of 16 hr (Jung ). In order to optimize treatment time for solid substance, test articles were treated for 10 or 30 min and post-incubated for 16 hr after washing. As a result, the exposure time appeared not to affect the assay results (Fig. 1A). The tissue viabilities following the treatment of aluminum hydroxide were determined to be 93.0 ± 1.0% and 85.3 ± 1.2% for the treatment times of 10 and 30 min, respectively. And the viabilities of potassium tetrafluoroborate were measured to be 90.4 ± 1.4% and 79.6 ± 10.0% for the treatment times of 10 and 30 min, respectively. Modified Maximum Average Score (MMAS) represents the average scoring of severity observed on cornea (0–80), iris (0–10) and conjunctiva (0–20) at 24, 48 and 72 hr after chemical treatment. MMAS of phenothiazine and potassium tetrafluoroborate is 0.0, and MMAS of aluminum hydroxide is 12.7 (Kaluzhny ). c.f. No/mild irritation MMAS <25; moderate irritation 25≤MMAS<59; and strong irritant MMAS ≥ 59. Moreover, tissue viability of these 3 test articles was about 100% in the EpiOcularTM and SkinEthic HCETM model. Our results fell within the range of non-irritant, however, we fixed treatment time to 10 min to be identical to the method used in liquid substances. Fig. 1C shows the treatment of solid substances (with PBS pre-loading) and washing procedure.

Modification of washing method

Some of solid chemicals, aluminum hydroxide, quinacrine and chlorhexidine, were difficult to wash off remaining powders from the treated tissue with the original washing method (wash 1). In order to wash powder cleaner for the correct prediction of eye irritant, we tried to modify washing protocol as shown as ‘materials and method’. As quinacrine and chlorhexidine are severe eye irritants (Cat 1), these were not affected by washing methods (Fig. 1B). However, cell viability of phenothiazine-treated tissues diverged substantially to 99.8 ± 3.0% and 62.7 ± 8.1% following ‘wash 2’ and ‘wash 3’ protocol, respectively. Likewise, cell viability of aluminum hydroxide was 93.0 ± 1.0% and 28.4 ± 0.2% with ‘wash 2’ and ‘wash 3’, respectively. Although aluminum hydroxide was not removed completely, ‘wash 3’ method was thought to be too harsh for non-irritants, so ‘wash 2’ protocol was selected for washing solid substances.

Predictive capacity of the eye irritation model

Additional 7 solid test materials were evaluated with this modified eye irritation test. When 50% of cell viability was set as the criteria for eye irritation potential evaluation according to that for liquid substances, all of the solid chemicals were predicted correctly (Fig. 2A, Table 2). Histological examination also supported the clear manifestation of irritation on the tissue (Fig. 2B). Moreover, repeated runs showed an excellent consistency between runs (Fig. 2A). This approach resulted in excellent sensitivity (100%) and specificity (100%). Consequently, an overall accuracy of 100% was obtained (Table 2). Pearson correlation analysis of tissue viability versus MMAS exhibited a high and significant correlation (Fig. 3A, correlation coefficient=−0.771, p=0.009) but the test appears to overestimate the toxicity of Cat 2 irritants compared to MMAS, which may reflect potential risk of high false negative rates (high sensitivity but low specificity). In addition, we also evaluated the cytotoxicity of several irritants that could be solubilized in culture medium (Fig. 3B). The results showed that cytotoxicity and tissue viability obtained in MCTT HCETM for the solid substances were comparable. However, since test articles are applied as it is (i.e., at 100% concentration) in MCTT HCETM, it was difficult to discriminate Cat 2 from Cat 1. Overall protocol for eye irritation test is described in Fig. 4.
Fig. 2.

Tissue viability obtained with the optimized eye irritation protocol. (A) Tissue viability results for 11 reference substances (n=3). (B) Histology of treated tissues (representative photograph). 2% SLS: 2% Sodium Lauryl Sulfate for positive control.

Table 2.

Predictive capacity of eye irritation test with MCTT HCETM for 11 solid substances

Test substanceGHSMCTT HCE
PhenothiazineNINI
Aluminum hydroxideNINI
Potassium tetrafluoroborateNINI
t-cinnamic acidNINI
Glyceryl stearateNINI
Ammonium nitrateCat 2I
Citric acidCat 2I
ChlorhexidineCat II
QuinacrineCat II
Promethazine hydrochlorideCat II
Zinc gluconateCat II
Sensitivity (%)100 (6/6)
Specificity (%)100 (5/5)
Accuracy (%)100 (11/11)
Fig. 3.

Comparison with in vivo MMAS and cytotoxicity on 2D HCE-T cells. (A) Tissue viability versus MMAS (substances with MMAS data available are presented in Table 1). (B) Cytotoxicity of eye irritants on human corneal cell-line, HCE-T. Mean ± SD (n=3).

Fig. 4.

Overview of the optimized eye irritation test method for MCTT HCETM model.

DISCUSSION

Many in vitro alternative test methods have been developed to replace conventional animal tests. However, for the most of in vitro cell-based assays, solid substances cannot be tested as it is but should be dissolved and diluted in appropriate vehicles for treatment. Poor solubility can pose a critical obstacle to the test conduct and the results can vary substantially depending on vehicles. In HCE models, solid test substances can be directly applied, circumventing these problems. However, to apply tissue engineered models to real in vitro test, the development of optimized test method and refinement of test protocol is indispensable to attain appropriate performance and accuracy of the test results (Jung ). Here we developed a new test method for the determination of eye irritation of solid substances with MCTT HCETM model and with the developed method, we demonstrated that MCTT HCETM model could predict the eye irritation of 11 solid chemicals quickly and correctly in comparison with other HCE models. Solid test materials are supposed to be applied for 90 min and then post-incubated for 18 hr in the EpiOcularTM model (Kaluzhny ; Pfannenbecker ). And in the LabCyte CORNEA-MODEL, another recently de veloped HCE model, solid substances are treated for 24 hr without post-incubation (Katoh ), reflecting that considerable time can be saved with MCTT HCETM model. In addition, in MCTT HCETM model, we could employ identical treatment time and post-incubation time for solid as used in liquid test substances through deploying separate washing schemes, which would be convenient and practical for the conduct of test. Most HCE models need separate treatment procedures for solid substances except for SkinEthic HCETM where different treatment time is applied according to eye peptide reactivity assay (EPRA) results (Alepee ). Generally, HCE models are provided in a 24 well format and 12 test substances can be tested in one kit of HCE model (duplicate). However, time setting for solid different from that for liquid substances can be problematic in terms of sample treatment layout and resultantly, models can be unnecessarily wasted. In this regard, eye irritation test using MCTT HCETM model can be more economic than other HCE models. BCOP and ICE tests can only identify Category 1 (severe) eye irritants which is a critical limitation for the application to the evaluation of drug substances and cosmetic ingredients. The eye irritation test with MCTT HCETM could distinguish severe to moderate eye irritants (Category 1 & Category 2) from non-irritants, yet the substances of Category 2, moderate to weak eye irritants, showed somewhat low cell viability, suggesting a potential risk of high false positive rate. This was further corroborated by additional test with 2D monolayer cell system, where substance of Category 2 could be differentiated. More substances of Category 2 and NI should be evaluated to clearly assess the predictive capacity of this model for the discrimination of Category 2 irritants. In addition, incorporation of secondary markers like IL-8 (Debbasch ), cornifelin expression (Choi ) or occludin expression (Meloni ) along with cell viability measurement may be helpful to enhance predictive capacity of this model for the determination of Category 2 eye irritants although further studies are necessary to confirm it. Along with the accuracy of 88% for liquid chemicals with MCT HCETM model (Jung ), this test method showed high accuracy of 100% for solid substances, reflecting that this model may be versatile for the test of diverse substances. We are continuing to expand the reference data employing various test substances to prove the predictive capacity and wide applicability of this model. Furthermore, intra- and inter-laboratory validation with 3 participating laboratories and the evaluation of accuracy are currently in progress. In conclusion, we optimized in vitro eye irritation test with MCTT HCETM model for solid substances through modifying the time of application and the methods of washing. Ten min was fixed for the application time of solid chemicals and suitable washing method (wash 2) was established for rinsing off solid substances on condition that test article was well-removed and cell viability was not decreased rapidly. Through this effort, we could demonstrate that this model could predict the eye irritation potential of 11 solid test substances with high accuracy (∼100% accuracy), which suggests that MCTT HCETM can be useful for the test of diverse drug candidates and cosmetic ingredients.
  22 in total

1.  Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation.

Authors:  Yulia Kaluzhny; Helena Kandárová; Patrick Hayden; Joseph Kubilus; Laurence d'Argembeau-Thornton; Mitchell Klausner
Journal:  Altern Lab Anim       Date:  2011-09       Impact factor: 1.303

2.  Establishment of a new in vitro test method for evaluation of eye irritancy using a reconstructed human corneal epithelial model, LabCyte CORNEA-MODEL.

Authors:  Masakazu Katoh; Fumiyasu Hamajima; Takahiro Ogasawara; Ken-ichiro Hata
Journal:  Toxicol In Vitro       Date:  2013-08-30       Impact factor: 3.500

3.  A new cell-based method for assessing the eye irritation potential of chemicals: an alternative to the Draize test.

Authors:  Sun-A Cho; Susun An; Eunyoung Lee; Kyeho Shin; Jun-Cheol Cho; Tae Ryong Lee
Journal:  Toxicol Lett       Date:  2012-05-15       Impact factor: 4.372

4.  The Draize Eye Test and in vitro alternatives; a left-handed marriage?

Authors:  M K Prinsen
Journal:  Toxicol In Vitro       Date:  2005-08-01       Impact factor: 3.500

5.  Lumican induces human corneal epithelial cell migration and integrin expression via ERK 1/2 signaling.

Authors:  Young Seomun; Choun-Ki Joo
Journal:  Biochem Biophys Res Commun       Date:  2008-05-12       Impact factor: 3.575

6.  Validation study of alternatives to the Draize eye irritation test in Germany: Cytotoxicity testing and HET-CAM test with 136 industrial chemicals.

Authors:  H Spielmann; S Kalweit; M Liebsch; T Wirnsberger; I Gerner; E Bertram-Neis; K Krauser; R Kreiling; H G Miltenburger; W Pape; W Steiling
Journal:  Toxicol In Vitro       Date:  1993-07       Impact factor: 3.500

7.  Local toxicity of benzalkonium chloride in ophthalmic solutions following repeated applications.

Authors:  Akihiko Okahara; Kouichi Kawazu
Journal:  J Toxicol Sci       Date:  2013       Impact factor: 2.196

8.  Identification of cornifelin and early growth response-1 gene as novel biomarkers for in vitro eye irritation using a 3D reconstructed human cornea model MCTT HCE™.

Authors:  Seunghye Choi; Miri Lee; Su-Hyon Lee; Haeng-Sun Jung; Seol-Yeong Kim; Tae-Young Chung; Tae-boo Choe; Young-Jin Chun; Kyung-Min Lim
Journal:  Arch Toxicol       Date:  2014-11-07       Impact factor: 5.153

9.  Occludin gene expression as an early in vitro sign for mild eye irritation assessment.

Authors:  Marisa Meloni; Aude Pauly; Barbara De Servi; Béatrice Le Varlet; Christophe Baudouin
Journal:  Toxicol In Vitro       Date:  2009-09-01       Impact factor: 3.500

10.  Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.

Authors:  Hong Liang; Aude Pauly; Luisa Riancho; Christophe Baudouin; Françoise Brignole-Baudouin
Journal:  Br J Ophthalmol       Date:  2011-03-22       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.